Literature DB >> 3865559

Physostigmine: an antidote for excessive central nervous system depression or paradoxical rage reactions resulting from intravenous diazepam.

J T Jastak.   

Abstract

A review of the pharmacology and use of the drug physostigmine is presented. Of particular interest is the drug's capability to reverse excessive somnolence or paradoxical responses caused by intravenous diazepam (Valium®) and other clinically available benzodiazepines. Its use for the treatment of anticholinergic syndrome is discussed and incidence and characterization of side effects documented. Recommendations are made for appropriate emergency use.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3865559      PMCID: PMC2148506     

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  31 in total

1.  The use of physostigmine as an antidote in accidental diazepam intoxication.

Authors:  J Di Liberti; M L O'Brien; T Turner
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

2.  Reversal of lorazepam delirium by physostigmine.

Authors:  C D Blitt; W C Petty
Journal:  Anesth Analg       Date:  1975 Sep-Oct       Impact factor: 5.108

3.  The tolerance and safety of intravenously administered benzyl alcohol in methylprednisolone sodium succinate formulations in normal human subjects.

Authors:  E Novak; S S Stubbs; E C Sanborn; R M Eustice
Journal:  Toxicol Appl Pharmacol       Date:  1972-09       Impact factor: 4.219

4.  Letter: Physostigmine reversal of sedative drugs.

Authors:  H Rosenberg
Journal:  JAMA       Date:  1974-08-26       Impact factor: 56.272

5.  Tricyclic antidepressant poisoning. Reversal of coma, choreoathetosis, and myoclonus by physostigmine.

Authors:  J S Burks; J E Walker; B H Rumack; J E Ott
Journal:  JAMA       Date:  1974-12-04       Impact factor: 56.272

6.  Case history number 74: reversal of phenothiazine-induced coma with physostigmine.

Authors:  W Bernards
Journal:  Anesth Analg       Date:  1973 Nov-Dec       Impact factor: 5.108

7.  Physostigmine therapy in acute tricyclic antidepressant poisoning.

Authors:  T L Slovis; J E Ott; D T Teitebaum; W Lipscomb
Journal:  Clin Toxicol       Date:  1971-09       Impact factor: 4.467

8.  Intravenous use of physostigmine in the management of acute diazepam intoxication.

Authors:  H L Vogel
Journal:  J Am Osteopath Assoc       Date:  1977-01

Review 9.  Drug therapy. Anticholinergics.

Authors:  D J Greenblatt; R I Shader
Journal:  N Engl J Med       Date:  1973-06-07       Impact factor: 91.245

10.  Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.

Authors:  R P Granacher; R J Baldessarini
Journal:  Arch Gen Psychiatry       Date:  1975-03
View more
  2 in total

1.  Pharmacological considerations for conscious sedation: clinical applications of receptor function.

Authors:  D E Becker
Journal:  Anesth Prog       Date:  1991 Mar-Apr

Review 2.  Paradoxical reactions to benzodiazepines in intravenous sedation: a report of 2 cases and review of the literature.

Authors:  Christian Robin; Norman Trieger
Journal:  Anesth Prog       Date:  2002
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.